Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
Neural Regulation01:37

Neural Regulation

39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

903
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
903

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson Disease.

JAMA neurology·2025
Same author

A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease.

Movement disorders clinical practice·2024
Same author

Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson's disease.

Expert review of neurotherapeutics·2024
Same author

Quality of life in people with epilepsy: The associations of anti-seizure medications and biopsychosocial variables.

Epilepsy & behavior : E&B·2024
Same author

Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia.

Movement disorders clinical practice·2022
Same author

Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.

Movement disorders clinical practice·2022
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K

Neuropsychology and Movement Disorders.

Julia A Thomas1, Alexander I Tröster1

  • 1Department of Clinical Neuropsychology, Barrow Neurological Institute, 222 West Thomas Road, Suite 315, Phoenix, AZ 85013, USA.

Neurologic Clinics
|September 29, 2024
PubMed
Summary
This summary is machine-generated.

Neuropsychology aids in diagnosing and treating movement disorders. This review covers cognitive profiles and treatments like neurosurgery and medication.

Keywords:
CognitionNeuropsychologyParkinson’s disease

More Related Videos

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.8K
Author Spotlight: Enhancing Remote Rehabilitation with Virtual Reality and Electromyography
04:06

Author Spotlight: Enhancing Remote Rehabilitation with Virtual Reality and Electromyography

Published on: January 12, 2024

573

Related Experiment Videos

Last Updated: Jun 11, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.8K
Author Spotlight: Enhancing Remote Rehabilitation with Virtual Reality and Electromyography
04:06

Author Spotlight: Enhancing Remote Rehabilitation with Virtual Reality and Electromyography

Published on: January 12, 2024

573

Area of Science:

  • Neuropsychology
  • Movement Disorders
  • Cognitive Science

Background:

  • Neuropsychology plays a crucial role in managing patients with movement disorders.
  • It aids in differential diagnosis, treatment planning, and surgical evaluation.
  • Support for patients and families is also enhanced through neuropsychological insights.

Purpose of the Study:

  • To review the cognitive profiles associated with various movement disorders.
  • To examine the neuropsychological literature concerning neurosurgic interventions.
  • To explore the role of cognitive-enhancing medications in movement disorder management.

Main Methods:

  • Literature review of neuropsychological studies.
  • Analysis of cognitive profiles in movement disorders.
  • Synthesis of research on neurosurgery and medication effects.

Main Results:

  • Specific cognitive deficits are characteristic of different movement disorders.
  • Neuropsychological assessments are vital for surgical candidacy and planning.
  • Cognitive-enhancing medications show potential in managing certain cognitive symptoms.

Conclusions:

  • Neuropsychology is integral to comprehensive care for movement disorder patients.
  • Understanding cognitive profiles informs personalized treatment strategies.
  • Further research is needed on neurosurgical and pharmacological interventions for cognitive aspects.